1. Li D, Semba S, Wu M, Yokozaki H. Molecular pathological subclassification of mucinous adenocarcinoma of the colorectum. Pathol Int. 2005;55(12):766–74. https://doi.org/10.1111/j.1440-1827.2005.01903.x.
2. Song W, Wu SJ, He YL, Cai SR, Zhang CH, Zhang XH, et al. Clinicopathologic features and survival of patients with colorectal mucinous, signet-ring cell or non-mucinous adenocarcinoma: experience at an institution in southern China. Chin Med J. 2009;122(13):1486–91.
3. Safaee A, Moghimi-Dehkordi B, Fatemi SR, Ghiasi S, Nemati-Malek F, Zali MR. Characteristics of colorectal mucinous adenocarcinoma in Iran. Asian Pac J Cancer Prev : APJCP. 2010;11(5):1373–5.
4. Catalano V, Loupakis F, Graziano F, Bisonni R, Torresi U, Vincenzi B, et al. Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer. Ann Oncol : Off J Eur Soc Med Oncol / ESMO. 2012;23(1):135–41. https://doi.org/10.1093/annonc/mdr062.
5. Bosman FT, Carneiro FT, World Health Organization., International Agency for Research on Cancer (IARC). WHO classification of tumours of the digestive system. World Health Organization classification of tumours, vol. 2. 4th ed. Lyon: IARC; 2010.